Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 9/20 | 0.57 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.56 |
| ▸ | QDPR | P09417 | 3/20 | 0.48 |
| ▸ | HTR6 | P50406 | 2/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.40 |
| ▸ | KHK | P50053 | 2/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4790435 | 0.76 | HTR2C (0.66) | HTR2CSIGMAR1QDPRHTR6HTR7 | |
| SCHEMBL30431801 | 0.76 | HTR2C (0.66) | HTR2CSIGMAR1QDPRHTR6HTR7 | |
| Hydrochloric Acid SCHEMBL9311920 | 0.75 | HTR2C (0.67) | HTR2CSIGMAR1QDPRHTR6HTR7 | |
| SCHEMBL4791120 | 0.74 | SIGMAR1 (0.79) | HTR2CSIGMAR1QDPRHTR6HTR7 | |
| SCHEMBL10162462 | 0.73 | MAT2A (0.33) | — | |
| SCHEMBL29914651 | 0.73 | HTR2C (0.66) | HTR2CSIGMAR1QDPR | |
| SCHEMBL21228136 | 0.73 | HTR2C (0.66) | HTR2CSIGMAR1QDPR | |
| Hydrochloric Acid SCHEMBL4793458 | 0.73 | HTR2C (0.79) | HTR2CSIGMAR1QDPRHTR6HTR7 | |
| SCHEMBL4510248 | 0.73 | HTR2C (1.00) | HTR2CSIGMAR1QDPRHTR6HTR7 | |
| SCHEMBL904011 | 0.73 | HTR2C (0.66) | HTR2CSIGMAR1QDPRHTR6HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150374677-A1 | ANALOGS OF PRIDOPIDINE, THEIR PREPARATION AND USE | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2015-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150374677-A1 | ANALOGS OF PRIDOPIDINE, THEIR PREPARATION AND USE | QDPR, DRD2, OPRD1 | HTR2C 69/4885SIGMAR1 14/4885QDPR 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.